readthroughSign in
CompanyNasdaqPetach Tikva, L3

PolyPid Ltd

PolyPid develops long-acting, controlled-release drugs for surgical care and metabolic diseases.

SCHEDULE 13G/ANov 13Latest SEC filing
Form DJun 23$27M sold